Logo

American Heart Association

  36
  0


Final ID:

Emerging Imaging Strategies to Manage Immunotherapy Cardiotoxicities

  • Neilan, Tomas  ( MASSACHUSETTS GENERAL HOSPITAL , Boston , Massachusetts , United States )
  • Thavendiranathan, Paaladinesh  ( U Toronto , Toronto , Ontario , Canada )
  • Palaskas, Nicolas  ( UT MD Anderson Cancer Center , Houston , Texas , United States )
  • Author Disclosures:
    Tomas Neilan: DO have relevant financial relationships ; Consultant:BMS:Active (exists now) ; Consultant:Pfizer:Active (exists now) ; Research Funding (PI or named investigator):Abbott:Active (exists now) ; Research Funding (PI or named investigator):AstraZeneca:Past (completed) ; Consultant:Merck:Active (exists now) ; Consultant:Roche:Active (exists now) ; Research Funding (PI or named investigator):BMS:Active (exists now) ; Consultant:Sanofi:Active (exists now) ; Consultant:Genentech:Active (exists now) | Paaladinesh Thavendiranathan: No Answer | Nicolas Palaskas: DO have relevant financial relationships ; Consultant:Kiniksa Pharmaceuticals:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

State of the Art Multimodality Imaging in Cardio-oncology

Monday, 11/10/2025 , 01:30PM - 02:45PM

Cardiovascular Seminar

More abstracts from these authors:
Hemodynamic Subtypes of Pulmonary Hypertension Based on Right Heart Catheterization Data Predict Outcomes in ICI-Associated Myocarditis

Wang Emily, Palaskas Nicolas, Ali Hyeon-ju, Ostos Mendoza Keila, Koutroumpakis Efstratios, Khalaf Shaden, Hamzeh Ihab, Kumar Salil, Iliescu Cezar, Deswal Anita

Top 5 Takeaways: Immune Checkpoint Inhibitors and Myocarditis

Stein-merlob Ashley, Kondapalli Lavanya, Neilan Tomas, Asnani Aarti

You have to be authorized to contact abstract author. Please, Login
Not Available